X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (125) 125
male (82) 82
female (72) 72
oncology (68) 68
index medicus (66) 66
aged (64) 64
hematology (62) 62
middle aged (60) 60
adult (32) 32
multiple myeloma (30) 30
treatment outcome (30) 30
multiple myeloma - drug therapy (28) 28
bortezomib (27) 27
aged, 80 and over (25) 25
antineoplastic combined chemotherapy protocols - therapeutic use (22) 22
prognosis (22) 22
antineoplastic agents - therapeutic use (21) 21
therapy (21) 21
hematology, oncology and palliative medicine (19) 19
genetics & heredity (17) 17
multiple myeloma - therapy (16) 16
retrospective studies (15) 15
chemotherapy (14) 14
diagnosis (14) 14
multiple myeloma - pathology (14) 14
remission induction (14) 14
survival (14) 14
in situ hybridization, fluorescence (13) 13
myeloma (13) 13
disease-free survival (12) 12
leukemia, myelogenous, chronic, bcr-abl positive - genetics (12) 12
multiple myeloma - diagnosis (12) 12
multiple myeloma - mortality (12) 12
chromosome aberrations (11) 11
care and treatment (10) 10
cll (10) 10
leukemia, lymphocytic, chronic, b-cell - genetics (10) 10
abridged index medicus (9) 9
antineoplastic combined chemotherapy protocols - adverse effects (9) 9
cyclophosphamide (9) 9
imatinib mesylate (9) 9
karyotyping (9) 9
leukemia (9) 9
risk factors (9) 9
thalidomide - analogs & derivatives (9) 9
translocation, genetic (9) 9
lenalidomide (8) 8
medicine & public health (8) 8
multiple-myeloma (8) 8
research (8) 8
survival rate (8) 8
thalidomide (8) 8
transplantation, autologous (8) 8
benzamides (7) 7
boronic acids - therapeutic use (7) 7
cancer (7) 7
cyclophosphamide - administration & dosage (7) 7
cytogenetics (7) 7
dexamethasone (7) 7
dexamethasone - administration & dosage (7) 7
dose-response relationship, drug (7) 7
hemic and lymphatic diseases (7) 7
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (7) 7
medical education (7) 7
multiple myeloma - blood (7) 7
pyrimidines - therapeutic use (7) 7
rituximab (7) 7
stem-cell transplantation (7) 7
transplantation (7) 7
trial (7) 7
vidarabine - analogs & derivatives (7) 7
adolescent (6) 6
age factors (6) 6
antineoplastic combined chemotherapy protocols - administration & dosage (6) 6
boronic acids - administration & dosage (6) 6
cell biology (6) 6
chronic myelogenous leukemia (6) 6
chronic myeloid-leukemia (6) 6
combined modality therapy (6) 6
cytogenetic analysis (6) 6
drug resistance, neoplasm (6) 6
drug therapy (6) 6
fatal outcome (6) 6
further section (6) 6
multiple myeloma - complications (6) 6
plasma cells - pathology (6) 6
pyrazines - administration & dosage (6) 6
pyrazines - therapeutic use (6) 6
recurrence (6) 6
regimen (6) 6
survival analysis (6) 6
thalidomide - administration & dosage (6) 6
vidarabine - administration & dosage (6) 6
acute disease (5) 5
autologous transplantation (5) 5
cells (5) 5
chromosome deletion (5) 5
chronic lymphocytic-leukemia (5) 5
chronic myeloid leukemia (5) 5
cml (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Reviews on Recent Clinical Trials, ISSN 1574-8871, 06/2016, Volume 11, Issue 2, pp. 124 - 127
Journal Article
Reviews on recent clinical trials, 2016, Volume 11, Issue 2, p. 124
The introduction of novel drugs in multiple myeloma therapy has changed disease survivals in last 15 years. Besides to be more effective in this disease new... 
Multiple Myeloma - drug therapy | Bortezomib | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Humans | Clinical Trials as Topic | Maintenance Chemotherapy | Thalidomide
Journal Article
American Journal of Hematology, ISSN 0361-8609, 06/2016, Volume 91, Issue 6, pp. 575 - 580
Journal Article
Journal of Neurosciences in Rural Practice, ISSN 0976-3147, 10/2013, Volume 4, Issue 4, p. 448
Journal Article
Journal of neurosciences in rural practice, ISSN 0976-3147, 10/2013, Volume 4, Issue 4, p. 448
Journal Article
Journal of Neurosciences in Rural Practice, ISSN 0976-3147, 10/2013, Volume 4, Issue 4, pp. 448 - 448
Journal Article
Central Nervous System Agents in Medicinal Chemistry, ISSN 1871-5249, 12/2014, Volume 14, Issue 1, pp. 23 - 27
Journal Article
Frontiers in Oncology, ISSN 2234-943X, 2014, Volume 4, p. 241
Multiple myeloma survival has significantly improved in the latest years due to a broad spectrum of novel agents available for treatment. The introduction of... 
Bortezomib | Lenalidomide | Myeloma | Thalidomide | therapy
Journal Article
Journal Article
Journal of Neurosciences in Rural Practice, ISSN 0976-3147, 2013, Volume 4, Issue 4, pp. 448 - 448
Journal Article
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.